Longevity.Technology notes that Daewoong Pharmaceutical has received a newly allowed US patent covering its experimental lipid delivery system for an mRNA platform for reprogramming aged cells.
Public source
Publisher name
Public post
A newly allowed US patent covers the lipid delivery system behind Daewoong Pharmaceutical's experimental mRNA platform for reprogramming aged cells. Link as first commen…
Company
Longevity.Technology
The #1 destination for daily news and insights on the fast-growth longevity market. LCW:the gateway to longevity clinics
- Industry
- Information Services
- Location
- London, GB
- Company size
- 11–50 employees
About Longevity.Technology
Just how close is technology that will enable humans to have hyper-extended lifespans? Closer than you think. Our mission is to bring together innovators, researchers, insurers, policy-makers, practitioners and commentators to address the new and fast-growing science and investment category that will shape the future of both the world’s population and the global economy: LONGEVITY
See moreLatest activity
Latest activity from Longevity.Technology
17 signals
People
Longevity.Technology announced that ex-Genentech exec Dr. Prasun Mishra is named to steer science toward the clinic for Longevica Therapeutics, Inc.
Partnerships
Longevity.Technology secured a licensing deal for Amprion's misfolded-protein test to bring it closer to European trial sites for neurodegenerative drug development.
Legal & Regulatory
Longevity.Technology notes that Celularity Inc. has secured a major manufacturing deal with Muse Cell Innovations to support the US production of MuseCells and strengthen its regenerative medicine pipeline.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
LongeVC
LongeVC company Sergey Jakimov notes that Generation Lab is offering a private cohort of celebrities, VCs, and biohackers early access to an undisclosed drug combination, with evidence showing insiders feel better.
Legal & Regulatory
The Alliance for Longevity Initiatives
The Alliance for Longevity Initiatives notes that the first draft of the bipartisan Cures in Care Initiative bill is expected this fall.
Research & Knowledge
longevitydocs.™
longevitydocs.™ reports that Robert Hariri built Celularity on placental-derived cell therapy. This week it started manufacturing someone else's platform: Dezawa MuseCells, MuseExosomes and MuseSecretome, at its Florham Park site.
Legal & Regulatory
Lifespanning
Lifespanning notes that Mississippi and South Carolina have issued clear warnings against using research-grade peptides in patient care, including that healthcare providers cannot recommend, supply, prescribe, or administer these products.
Research & Knowledge
LinkGevity